Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
≥10-≤20 ≥1.0-≤5.0
EC/CAS
7429-90-5
Name of the chemical
Aluminium
Concentration
≥1.0-≤5.0
EC/CAS
2451-62-9
Name of the chemical
1,3,5-Tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione (TGIC)
Concentration
<1.0
General Information
Version
4
Revision date
2020-10-30
Product name
GRAY EPOXI-POLYESTER SMOOTH METALLIC
1.2.1 Relevant identified uses
Industrial applications
1.2.2. Uses advised against
Coating. Paints. Painting-related materials
Manufacturer Name
PPG Industries, Inc
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H340, H351
Hazard statements
Code
Statements
H340
May cause genetic defects
Section 2
SECTION 2: Hazards identification
Classification of the GERM CELL MUTAGENICITY - Category 1B substance or mixture CARCINOGENICITY - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity 56.5% (oral), 62.3% (dermal), 87.3% (inhalation)
Signal word
Danger
Hazard statements
H340 - May cause genetic defects. H351 - Suspected of causing cancer.
Prevention
P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves, protective clothing and eye or face protection.
Response
P308 + P313 - IF exposed or concerned: Get medical advice or attention.
Storage
Not applicable.
Disposal
Not applicable.
Other hazards which do not result in classification
Handling and/or processing of this material may generate a dust which can cause mechanical irritation of the eyes, skin, nose and throat. Emits toxic fumes when heated. See toxicological information (Section 11)
2.1 Classification of the substance or mixture
GERM CELL MUTAGENICITY - Category 1B substance or mixture CARCINOGENICITY - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 56.5% (oral), 62.3% (dermal), 87.3% (inhalation)
